scholarly article | Q13442814 |
P356 | DOI | 10.1042/CS20150153 |
P698 | PubMed publication ID | 26957644 |
P50 | author | Kay L Double | Q57548330 |
P2093 | author name string | Julian F B Mercer | |
Katherine M Davies | |||
Nicholas Chen | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Parkinson's disease | Q11085 |
P304 | page(s) | 565-574 | |
P577 | publication date | 2016-04-01 | |
P1433 | published in | Clinical Science | Q372419 |
P1476 | title | Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics | |
P478 | volume | 130 |
Q92703211 | Case of Early-Onset Parkinson's Disease in a Heterozygous Mutation Carrier of the ATP7B Gene |
Q37209945 | Coordination Environment of Cu(II) Ions Bound to N-Terminal Peptide Fragments of Angiogenin Protein. |
Q89511106 | Copper Ions and Parkinson's Disease: Why Is Homeostasis So Relevant? |
Q47408660 | Copper and Zinc Homeostasis: Lessons from Drosophila melanogaster |
Q59600524 | Copper chaperone blocks amyloid formation via ternary complex |
Q51650805 | Copper comes of age in Melbourne. |
Q90310172 | Copper induce zebrafish retinal developmental defects via triggering stresses and apoptosis |
Q57801718 | Copper signalling: causes and consequences |
Q47611418 | Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism |
Q90319955 | Differential effects of Cu2+ and Fe3+ ions on in vitro amyloid formation of biologically-relevant α-synuclein variants |
Q52714245 | Emerging Disease-Modifying Strategies Targeting α-Synuclein for the Treatment of Parkinson Disease. |
Q92623198 | Folding of copper proteins: role of the metal? |
Q93133706 | Lentinula edodes as a Source of Bioelements Released into Artificial Digestive Juices and Potential Anti-inflammatory Material |
Q64771830 | Localization of the Locus Coeruleus in the Mouse Brain |
Q93083418 | Medicinal chemistry of acridine and its analogues |
Q92028537 | Metal Chelation Therapy and Parkinson's Disease: A Critical Review on the Thermodynamics of Complex Formation between Relevant Metal Ions and Promising or Established Drugs |
Q37737068 | Metallothionein, Copper and Alpha-Synuclein in Alpha-Synucleinopathies. |
Q51735978 | Multimodal LA-ICP-MS and nanoSIMS imaging enables copper mapping within photoreceptor megamitochondria in a zebrafish model of Menkes disease. |
Q46309593 | Occupational Metal Exposure and Parkinsonism |
Q40406670 | Outlining a Population "at Risk" of Parkinson's Disease: Evidence from a Case-Control Study. |
Q64998488 | Pentiptycene-Derived Fluorescence Turn-Off Polymer Chemosensor for Copper(II) Cation with High Selectivity and Sensitivity. |
Q48514121 | Rare Disease Mechanisms Identified by Genealogical Proteomics of Copper Homeostasis Mutant Pedigrees |
Q95299201 | Rare Genetic Diseases: Nature's Experiments on Human Development |
Q58614416 | Redox nanoparticles: synthesis, properties and perspectives of use for treatment of neurodegenerative diseases |
Q48004140 | Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of 64Cu acetate and 64CuGTSM. |
Q47614352 | Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain. |
Q64243678 | Switching on Endogenous Metal Binding Proteins in Parkinson's Disease |
Q90423306 | Targeting of copper-trafficking chaperones causes gene-specific systemic pathology in Drosophila melanogaster: prospective expansion of mutational landscapes that regulate tumor resistance to cisplatin |
Q57493310 | The Influence of Heavy Metals and Trace Elements on Comatose Patients with Severe Traumatic Brain Injury in the First Week of Admission |
Q39235096 | The emerging role of retromer in neuroprotection |
Q33591202 | The interactome of the copper transporter ATP7A belongs to a network of neurodevelopmental and neurodegeneration factors. |
Search more.